Global Endocrine Testing Market 2015-2019

Global Endocrine Testing Market 2015-2019

Category : Diagnostic and Biotech
Published On : June  2015
Pages : 101



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
About Endocrine Testing Systems

Endocrine testing system refers to a collection of tests that involve all the glands of the body and the hormones produced by those glands. The endocrine system 
together with nervous system regulates and controls many internal body functions. While the endocrine system uses chemical messengers called hormones, the nervous 
system uses nerve impulses as a means of control. The endocrine system plays a role in reproduction, growth and sexual development, responses to injury and stress, 
body energy levels, bone and muscle strength, and internal balance of the body. 

Technavio's analysts forecast the global endocrine testing market to grow at a CAGR of 4.66% over the period 2014-2019.

Covered in this Report

In this report, Technavio covers the present scenario and the growth prospects of the global endocrine testing market for the period 2015-2019. To calculate the market 
size, we consider the revenue generated from the sales of the products (instruments and reagents) used in the following endocrine testing technologies: 

Types of Diagnostic Technologies
• Clinical chemistry technologies
• Immunoassay technologies
• Tandem mass spectrometry
• Monoclonal and polyclonal antibodies
• Sensor technologies
• Others

The report also provides information about the following endocrine tests:
• FSH
• TSH
• hCG
• DHEAS
• Progesterone
• Testosterone
• Insulin
• Prolactin 
• Cortisol
• Estradiol
• Luteinizing Hormone

This report covers the present scenario and the growth prospects of the endocrine testing market for the period 2015-2019 mainly for three regions: 

Americas: The principal countries in the Americas are the US, Canada, Mexico, and Brazil.

EMEA: The principal countries focused in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and 
UAE. 

APAC: The principal countries focused in this region are Japan, China, Australia, Singapore, South Korea, and India. 

Technavio's report, Global Endocrine Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report 
covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. 

Key Regions 
• Americas
• APAC 
• EMEA

Key Vendors
• Abbott Diagnostics
• Diascorin 
• Roche Diagnostics
• Siemens Healthcare
• Thermo Fisher Scientific

Other Prominent Vendor
• AdnaGen
• Alere
• Allele Biotechnology
• Axis-Shield 
• Beckman CoulterDanaher
• Biomedical Diagnostics
• BioMerieux
• Bio-Rad
• Diametra
• Enzo Life Sciences
• Fujirebio
• ImmunoDX
• Immunonodiagnostics System 
• InDevR
• Innogenetics
• Kyowa Medex
• Merck Millipore
• Meridian Bioscience
• Meso Scale Discovery 
• NanoEnTek 
• Nova Century Scientific
• Ortho-Clinical Diagnostics
• Quidel
• Randox
• SDIX
• Sysmex
• Tecan 
• Tosoh Bioscience
• Vital Diagnostics 
• ZEUS Scientific

Market Driver
• Growing Aging Population
• For a full, detailed list, view our report

Market Challenge
• Limited Detection and Complexity of Immunoassays
• For a full, detailed list, view our report

Market Trend
• Automation and System Integration
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Tests
08. Market Segmentation by Diagnostic Technology
08.1 Global Clinical Chemistry Technology Market
08.1.1 Market Size and Forecast
08.2 Global Immunoassay Technology Market
08.2.1 Market Size and Forecast
08.3 Global Monoclonal and Polyclonal Antibodies Technology Market
08.3.1 Market Size and Forecast
08.4 Global Tandem Mass Spectrometry Technology Market
08.4.1 Market Size and Forecast
08.5 Global Sensor Technology Market
08.5.1 Market Size and Forecast
09. Geographical Segmentation
09.1 Endocrine Testing Market in Americas
09.1.1 Market Size and Forecast
09.2 Endocrine Testing Market in EMEA
09.2.1 Market Size and Forecast
09.3 Endocrine Testing Market in APAC
09.3.1 Market Size and Forecast
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
17.1 Competitive Scenario
17.1.1 Key News
17.1.2 Mergers and Acquisitions
17.2 Market Share Analysis 2014
17.2.1 Abbott
17.2.2 DiaSorin
17.2.3 Roche
17.2.4 Siemens Healthcare
17.2.5 Thermo Fisher
17.3 Other Prominent Vendors
18. Key Vendor Analysis
18.1 Abbott Diagnostics
18.1.1 Key Facts
18.1.2 Business Overview
18.1.3 Geographical Presence
18.1.4 SWOT Analysis
18.2 DiaSorin
18.2.1 Key Facts
18.2.2 Business Overview
18.2.3 Business Segmentation by Revenue 2013
18.2.4 Business Segmentation by Revenue 2012 and 2013
18.2.5 Geographical Segmentation by Revenue 2013
18.2.6 Business Strategy
18.2.7 Recent Developments
18.2.8 SWOT Analysis
18.3 Roche Diagnostics
18.3.1 Key Facts
18.3.2 Business Overview
18.3.3 Business Segmentation by Revenue 2014
18.3.4 Business Segmentation by Revenue 2013 and 2014
18.3.5 Geographical Segmentation by Revenue 2014
18.3.6 Business Strategy
18.3.7 Recent Developments
18.3.8 SWOT Analysis
18.4 Siemens Healthcare Diagnostics
18.4.1 Key Facts
18.4.2 Business Overview
18.4.3 SWOT Analysis
18.5 Thermo Fisher Scientific
18.5.1 Key Facts
18.5.2 Business Overview
18.5.3 Business Segmentation by Revenue 2014
18.5.4 Business Segmentation by Revenue 2013 and 2014
18.5.5 Geographical Segmentation by Revenue 2014
18.5.6 Business Strategy
18.5.7 Recent Developments
18.5.8 SWOT Analysis
19. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Snapshot of Global Endocrine Testing Market 2014-2019
Exhibit 3: Global Endocrine Testing Market 2014-2019 ($ millions)
Exhibit 4: Global Endocrine Testing Market Segmentation by Type of Tests
Exhibit 5: Global Endocrine Testing Market Segmentation by Type of Tests 2014
Exhibit 6: Normal FSH Level (depends on age and gender)
Exhibit 7: TSH Standard Reference Levels
Exhibit 8: TSH Levels during Pregnancy
Exhibit 9: hCG Levels in Early Pregnancy
Exhibit 10: DHEAS Levels
Exhibit 11: Progesterone Levels During Different Phases of the Menopause Cycle and Pregnancy
Exhibit 12: Normal Levels of Testosterone
Exhibit 13: Glucose Levels
Exhibit 14: Standard Levels of Prolactin
Exhibit 15: Normal Cortisol Levels
Exhibit 16: Normal Estradiol Levels
Exhibit 17: Normal LH Levels
Exhibit 18: Segmentation of Global Endocrine Testing Market by Type of Diagnostic Technology
Exhibit 19: Segmentation of Global Endocrine Testing Market by Technology 2014
Exhibit 20: Global Clinical Chemistry Technology Market 2014-2019 ($ millions)
Exhibit 21: Global Immunoassay Technology Market 2014-2019 ($ millions)
Exhibit 22: Global Monoclonal and Polyclonal Antibodies Technology Market 2014-2019 ($ millions)
Exhibit 23: Global Tandem Mass Spectrometry Technology Market 2014-2019 ($ millions)
Exhibit 24: Global Sensor Technology Market 2014-2019 ($ millions)
Exhibit 25: Global Endocrine Testing Market Segmentation Analysis 2014-2019
Exhibit 26: Segmentation of Global Endocrine Testing Market by Type of Technology 2014-2019
Exhibit 27: Global Endocrine Testing Market by Geographical Segmentation 2014
Exhibit 28: Endocrine Testing Market in Americas 2014-2019 ($ millions)
Exhibit 29: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
Exhibit 30: Endocrine Testing Market in EMEA 2014-2019 ($ millions)
Exhibit 31: Global Endocrine Testing Market by Geography 2014-2019 in ($ millions)
Exhibit 32: Global Endocrine Testing Market by Geography 2014-2019
Exhibit 33: Percentage of Elderly Aged above 65 in Different Regions 2012 and 2050
Exhibit 34: Estimated Percentage of Elderly Population 2012 and 2050
Exhibit 35: Abbott: Key Takeaways
Exhibit 36: DiaSorin: Revenue by Technology 2014
Exhibit 37: DiaSorin: Key Takeaways
Exhibit 38: Roche: Key Takeaways
Exhibit 39: Siemens Healthcare: Key Takeaways
Exhibit 40: Thermo Fisher: Key Takeaways
Exhibit 41: Abbott Diagnostics: Geographical Presence
Exhibit 42: DiaSorin: Business Segmentation by Revenue 2013
Exhibit 43: DiaSorin: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 44: DiaSorin: Geographical Segmentation by Revenue 2013
Exhibit 45: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 46: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 47: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Exhibit 48: Thermo Fisher Scientific: Business Segmentation by Revenue 2014
Exhibit 49: Thermo Fisher Scientific: Business Segmentation by Revenue 2013 and 2014 ($ billion)
Exhibit 50: Thermo Fisher Scientific: Geographical Segmentation by Revenue 2014

Enquiry Before Buy
image
Can´t read the image ? refresh here.